Glial fibrillary acidic protein (GFAP), a marker of astrocytes and astrogliosis, is one of the “neuroinflammation-related markers” that has limited diagnostic utility for AD but has demonstrated prognostic potential. This evidence concerns the gene GFAP and Alzheimer disease.